Decisions

Date	Case	Division	Action	Motion	Outcome	Summary
2025-02-14	APL_39664/2024	Court of Appeal	Appeal RoP220.1	motionName.appeal_decision	PI granted	Court of Appeal Panel 2 set aside the The Hague Local Division's refusal to grant provisional measures, and granted a preliminary injunction in favour of Abbott Diabetes Care Inc. against Sibio Technology Limited and Umedwings Netherlands B.V. concerning EP 3 831 283 (continuous glucose monitoring device). The Court found the patent valid (overcoming added matter and other validity challenges) and likely infringed by Sibionics' GS1 Device. A general injunction was ordered against all infringing acts in UPC Contracting Member States. Sibionics was also ordered to provide origin/distribution chain information and to deliver up infringing products. Penalty payments of EUR 10,000 per infringing product or EUR 100,000 per day were imposed.
2024-08-19	UPC_CoA_388/2024	Court of Appeal	Generic Order	—	Procedural only	The Court of Appeal partially granted Sibio's request for suspensive effect of their appeal, specifically to the extent that the first-instance provisional measures order erroneously covered Ireland (which had not ratified the UPCA and therefore was not a Contracting Member State). The erroneous extension to Ireland was identified as a manifest error.